Good point! The result should be that doctors will prescribe the "safest" drug, for which there are no generics yet due to the renewed patents. Perhaps that's e

Good point! The result should be that doctors will prescribe the "safest" drug, for which there are no generics yet due to the renewed patents. Perhaps that's even more important than the marketing thing.